Genica Bioscience
Genica Bioscience is a Hyderabad-based, founder-led Indian biotechnology company (1-10 employees) that develops and sells recombinant proteins, diagnostic kits, and animal-free research reagents, and offers custom recombinant protein and diagnostic assay development services to pharmaceutical, biotech, and research-institution customers via direct, quote-based sales.
- Company typePrivate
- Founded2021
- HeadquartersHyderabad, India
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Genica Bioscience does
Genica Bioscience (also styled 'Genica Biosciences') is a privately held, founder-led biotechnology company based in Hyderabad, India, operating from a laboratory at the AIC-CCMB incubator facility (IDA-Uppal, Habsiguda) with a registered office in Nacharam. The company was founded by Dr. Roopa Jones (Ph.D., CSIR-IICT), who directs all reported operations and brings 18 years of molecular biology and protein expression expertise. Core technology spans recombinant protein production across bacterial, yeast, and mammalian expression systems, diagnostic assay development, and protein engineering, with an explicit emphasis on animal-free recombinant reagents that eliminate animal-derived components from research workflows. The product portfolio comprises nine SKUs: recombinant hyaluronidase, recombinant antibodies, animal-free reagents, animal-free alternative methods, recombinant endotoxin testing kits, thermostable proteins/enzymes/mAbs, drug delivery adjuvants, industrial/pharmaceutical enzymes, and recombinant growth factors.
The commercial model combines one-time product sales (diagnostic kits, recombinant proteins, endotoxin testing kits, research reagents) with contract research and custom development services covering gene cloning, expression optimization, protein purification, and characterization. Pricing is not publicly disclosed; the website routes all inquiries through a 'Get Quote' contact form, indicating project-based, quote-driven transactions rather than standardized e-commerce. Distribution is direct-to-customer via the corporate website, supported by a presence on LinkedIn, Facebook, Twitter/X, and Instagram. The company targets three primary customer segments: pharmaceutical and biotechnology companies, research institutions and laboratories, and biotech startups/ventures seeking consulting and development support.
Genica Bioscience employs 1-10 people, has not disclosed any institutional funding, acquisitions, partnerships, patents, trademarks, certifications, or regulatory approvals, and reports only one named customer testimonial (Real-Gene Labs). The website asserts a 'global impact' positioning, though no international offices, distributor agreements, or non-India customer references are evidenced. The company's website also contains 'Over 10 years we help companies reach their financial and branding goals' language that is template text inherited from the WordPress 'Maxbizz' theme rather than a genuine tenure claim, which materially limits the credibility of its scale commentary.
Genica Bioscience firmographics
Firmographics- Name
- Genica Bioscience
- Legal name
- Genica Biosciences
- Website
- https://genica.in
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Genica Bioscience is a Hyderabad-based, founder-led Indian biotechnology company (1-10 employees) that develops and sells recombinant proteins, diagnostic kits, and animal-free research reagents, and offers custom recombinant protein and diagnostic assay development services to pharmaceutical, biotech, and research-institution customers via direct, quote-based sales.
- Ownership category
- akta.pro rank
Genica Bioscience industry classification
Industry- Product category
- Biotechnology Reagents and Recombinant Proteins
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Recombinant Protein Therapeutics (enzymes, hormones, growth factors) (HLAAAAAB)
Keywords
Where Genica Bioscience is headquartered
LocationHeadquarters
- HQ city
- Hyderabad
- HQ country
- India
- HQ region
- Asia
Offices2 records
Markets served
Genica Bioscience business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
Revenue model
- Diagnostic Kit Sales: Sale of diagnostic kits for infectious diseases, genetic disorders, and cancer screening applications
- Recombinant Protein Products: Sale of recombinant proteins including hyaluronidase, growth factors, enzymes, and monoclonal antibodies for research and pharmaceutical applications
- Contract Research and Development Services: Consulting services and custom recombinant protein development including gene cloning, expression optimization, and protein purification
- Research Reagents: Sale of recombinant animal-free reagents and alternative methods for research applications
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Genica Bioscience product offering
Product offeringCore offering
Genica Bioscience develops, manufactures, and sells recombinant biological products—including hyaluronidase, monoclonal antibodies, animal-free reagents, endotoxin testing kits, thermostable proteins/enzymes, drug delivery adjuvants, industrial enzymes, and growth factors—and delivers contract research services in diagnostic kit development and custom recombinant protein engineering for pharmaceutical, biotechnology, and research customers.
Product overview
Genica Bioscience is a biotechnology company offering a portfolio of recombinant protein products and development services. The product portfolio includes nine distinct offerings: Recombinant Hyaluronidase, Recombinant Antibodies, Recombinant Animal-Free Reagents, Animal-Free Alternative Methods, Recombinant Endotoxin Testing Kit, Thermostable Proteins/Enzymes/mAbs, Drug Delivery Adjuvants, Industrial/Pharmaceutical Enzymes, and Recombinant Growth Factors. These products are complemented by two core services: Diagnostic Kit Development and Recombinant Protein Development. The offerings collectively enable research, diagnostics, and therapeutic applications across pharmaceuticals, biotechnology, and cosmetics sectors, with a focus on animal-free and recombinant technologies.
Differentiator
Problem solved
Functional benefit
Products and services
- Recombinant Hyaluronidase High-purity recombinant hyaluronidase enzymes engineered for optimal activity and stability, facilitating efficient degradation of hyaluronic acid in pharmaceutical, medical, and cosmetic formulations for enhanced drug delivery and tissue permeability.
- Recombinant Antibodies Customizable recombinant antibody platforms delivering versatile and high-affinity solutions for research, diagnostics, and therapy with superior specificity and efficacy.
- Recombinant Animal-Free Reagents High-quality reagents produced through recombinant technology that eliminate animal-derived components for safer and more reliable research applications.
- Animal-Free Alternative Methods Innovative alternative methods that replace animal experimentation, ensuring ethical research practices and reliable results without animal-derived inputs.
- Recombinant Endotoxin Testing Kit Comprehensive endotoxin testing kits for detection and quantification of endotoxins in pharmaceutical and biotechnology products, ensuring safety and compliance.
- Thermostable Proteins, Enzymes and mAbs Thermostable proteins, enzymes, and monoclonal antibodies with enhanced stability and functionality enabling a wide range of research and therapeutic applications.
- Drug Delivery Adjuvants Drug delivery adjuvants designed to improve efficacy and safety of pharmaceutical formulations including monoclonal antibodies, vaccines, and drugs, facilitating targeted delivery and enhancing therapeutic outcomes.
- Industrial/Pharmaceutical Enzymes Meticulously engineered industrial and pharmaceutical enzymes offering enhanced efficiency and reliability in industrial processes and pharmaceutical development.
- Recombinant Growth Factors Highly pure and biologically active recombinant growth factors to stimulate cell proliferation, differentiation, and tissue regeneration for research, cosmetic, and therapeutic applications.
- Diagnostic Kit Development Service Specialized diagnostic kit development services leveraging molecular biology, assay development, and quality control expertise for accurate, reliable, and rapid results in infectious diseases, genetic disorders, and cancer screening applications.
- Recombinant Protein Development Service Comprehensive recombinant protein development services encompassing gene cloning, expression optimization, protein purification, and characterization for therapeutic proteins and industrial enzymes.
Companies that use Genica Bioscience
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Genica Bioscience technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Genica Bioscience partnerships and signals
Strategic signalScale indicators2 records
Recent moves4 records
Expansion highlights4 records
Genica Bioscience competitors and assessment
Company assessmentRegional players
- Syngene International: Syngene International is an India-based CRO/CDMO offering recombinant protein production, assay development, and biologics manufacturing services. Comparable to Genica's recombinant protein and diagnostic kit development services at significantly greater scale.
- HiMedia Laboratories: HiMedia is an India-based manufacturer of microbiology, molecular biology, and diagnostic reagents, including animal-free alternatives and recombinant enzymes. Comparable to Genica's animal-free reagent and diagnostic kit lines within the Indian market.
- Premas Biotech: Premas Biotech is an India-based contract research and recombinant protein/vaccine developer headquartered in Gurugram. Closest India-based peer to Genica in scale and service mix (recombinant proteins, diagnostic and therapeutic R&D).
Direct peers
- Abcam (Danaher): Abcam supplies recombinant antibodies and protein research reagents globally and is now part of Danaher's life sciences segment. Directly comparable to Genica's recombinant antibody and reagent catalog, though with much broader inventory.
- Twist Bioscience: Twist Bioscience provides synthetic DNA, antibody libraries, and recombinant protein engineering services. Comparable to Genica in gene cloning and recombinant protein/antibody production, though with a stronger synthetic biology angle.
- Bio-Techne (Novus Biologicals / R&D Systems): Bio-Techne is a major manufacturer of purified recombinant proteins, antibodies, and assay reagents (under R&D Systems and Novus Biologicals brands) used by pharma, diagnostics, and academic labs worldwide. Strong product overlap with Genica's growth factors, enzymes, and antibody offerings.
- Sino Biological: Sino Biological develops and manufactures recombinant proteins, antibodies, and related reagents for research and diagnostic use. Direct overlap with Genica's recombinant protein catalog, including growth factors, enzymes, and antibodies.
- GenScript: GenScript is a global contract research organization offering custom recombinant protein expression, gene synthesis, antibody services, and diagnostic reagent development. Highly comparable to Genica across both service and product lines, though at vastly greater scale.
Broad incumbents
- Merck MilliporeSigma (Bioprocessing): Merck's Life Science business supplies recombinant proteins, industrial enzymes, pharmaceutical-grade excipients, and bioprocessing reagents. Comparable to Genica's industrial/pharmaceutical enzymes and recombinant reagent portfolio.
- Thermo Fisher Scientific (Life Sciences): Thermo Fisher offers recombinant proteins, antibodies, diagnostic development tools, and endotoxin testing reagents through its Life Sciences and Specialty Diagnostics segments. Overlaps with Genica's full product range but as part of a far broader catalog.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Genica Bioscience social profiles
Digital presenceGenica Bioscience financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genica Bioscience leadership team
Management profileNumber of profiles
Profiles1 record
Genica Bioscience funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genica Bioscience M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genica Bioscience
What does Genica Bioscience do?
Genica Bioscience develops, manufactures, and sells recombinant biological products—including hyaluronidase, monoclonal antibodies, animal-free reagents, endotoxin testing kits, thermostable proteins/enzymes, drug delivery adjuvants, industrial enzymes, and growth factors—and delivers contract research services in diagnostic kit development and custom recombinant protein engineering for pharmaceutical, biotechnology, and research customers.
Is Genica Bioscience a public or private company?
Genica Bioscience is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Genica Bioscience founded?
Genica Bioscience was founded in 2021. It employs 1 to 10 people.
Where is Genica Bioscience based?
Genica Bioscience is headquartered in Hyderabad, India, in the Asia region.
How does Genica Bioscience make money?
Four revenue lines are on record. Diagnostic Kit Sales are the primary driver. The others are recombinant Protein Products, contract Research and Development Services and research Reagents.
Who are Genica Bioscience's main competitors?
Regional players on record are Syngene International, HiMedia Laboratories and Premas Biotech. Direct peers are Abcam (Danaher), Twist Bioscience, Bio-Techne (Novus Biologicals / R&D Systems), Sino Biological and GenScript. Broad incumbents are Merck MilliporeSigma (Bioprocessing) and Thermo Fisher Scientific (Life Sciences).
Does Genica Bioscience have an API?
No public API is recorded for Genica Bioscience.
What industry is Genica Bioscience in?
Genica Bioscience's product category is Biotechnology Reagents and Recombinant Proteins. Its primary akta.pro industry code is HLAAAAAB, Recombinant Protein Therapeutics (enzymes, hormones, growth factors). Its NAICS code is 325414 and its SIC code is 2836.